Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2005
12/28/2005CN1713888A Cream for treatment of skin injured by the sun
12/28/2005CN1712067A Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer
12/28/2005CN1711996A Injectable pharmaceutical compositions comprising sodium diclofenac and beta-cyclodextrin
12/28/2005CN1233421C Plasmid for gene therapy of cardiac muscle
12/28/2005CN1233420C Method for preparation of polymeric micelle via separation of block copolymer
12/28/2005CN1233419C Fe3O4 magnetofluid and its preparation
12/28/2005CN1233418C Heat-resisting lyophilized protectant for chicken newcastle disease, chicken infectious bronchitis (H120, H52) dual lyophilized vaccine and preparing process thereof
12/28/2005CN1233320C Slow-releasing microball with nimoldipine and its preparing method
12/28/2005CN1233257C A composition containing carvacrol and thymol for use as abactericide
12/27/2005US6979730 Nucleic acids encoding prostate stem cell antigen
12/27/2005US6979726 Immunoconjugates
12/27/2005US6979676 Pharmaceutical composition containing and indolopyrrolocarbazole derivative
12/27/2005US6979674 A sustained-release pharmaceutical formulation containing a granulocyte-colony stimulating factor (G-CSF), polyol:oil and a thickener
12/27/2005US6979672 Cyclosporin-based pharmaceutical compositions
12/27/2005US6979467 Microcapsules IV
12/27/2005US6979464 Random copolymer of an N-alkyl- or N,N-dialkyl(meth)acrylamide and a hydrophilic comonomer; may be a graft polymer; drug delivery
12/27/2005US6979463 Stable extended release oral dosage composition
12/27/2005US6979461 Method for producing liposome preparation
12/27/2005US6979458 high dosage form of a glucosamine and chondroitin nutraceutical mixture with vitamins B3, C and E, sodium hyaluronate and a solubilizer; fast absorbing, tasteless, odorless; non-steroidal antiinflammatory agents; vasodilator
12/27/2005US6979455 producing concentrate from a carrier having a modified ethylene polymer and optionally an olefin polymer, with one or more biocidal antimicrobial agents compounded therein; does not exhibit chalking and clumping of antimicrobial agent on surface
12/27/2005US6979454 Biologically active composition
12/27/2005US6979442 granulocyte colony stimulating factor (G-CSF) and a stabilizing buffer; sustained release; for preventing or treating infections in mammals
12/27/2005US6979441 Method for topical treatment of carpal tunnel syndrome
12/27/2005US6979437 Drug delivering by inhaling or breathing to respiratory tract with a reduced drug dosage, comparing with traditional oral administration; dry powder drugs, emergency treatment
12/27/2005US6978945 Dispensing device
12/27/2005CA2337509C Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
12/27/2005CA2327187C Transdermal therapeutic system containing pergolide
12/27/2005CA2280099C Medical aerosol formulations
12/27/2005CA2252050C Buccal, non-polar spray or capsule
12/27/2005CA2166001C Stable solid formulation of enalapril salt and process for preparation thereof
12/22/2005WO2005121369A2 Rna-containing microvesicles and methods therefor
12/22/2005WO2005121341A1 Tumor specific antibody
12/22/2005WO2005121215A2 Polypeptides with the capacity to entrap drugs and release them in a controlled way
12/22/2005WO2005121196A1 Novel temperature and ph sensitive copolymers
12/22/2005WO2005121181A1 Multi-drop tree branching polyethylene glycol-oligopeptides and active derivates and pharmaceutical compounds there of
12/22/2005WO2005120588A2 Peptides delivered to cell nuclei
12/22/2005WO2005120585A1 Dual function polymer micelles
12/22/2005WO2005120579A1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity
12/22/2005WO2005120578A2 Biodegradable drug-polymer delivery system
12/22/2005WO2005120577A2 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity
12/22/2005WO2005120563A2 Induction of an immune response against streptococcus pneumoniae polysaccharides
12/22/2005WO2005120552A1 METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION
12/22/2005WO2005120551A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
12/22/2005WO2005120546A2 Compositions and methods for topical diagnostic and therapeutic transport
12/22/2005WO2005120490A1 Capsule stable against mastication
12/22/2005WO2005120487A2 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders
12/22/2005WO2005120470A1 Matrix-controlled transdermal therapeutic system based on an adhesive for administering norelgestromin or the combination thereof with an estrogen
12/22/2005WO2005120459A2 Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
12/22/2005WO2005120458A1 Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
12/22/2005WO2005120457A1 Immune enhancing compositions and methods of use thereof
12/22/2005WO2005120453A1 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons
12/22/2005WO2005120407A2 Preparation for localized delivery of therapeutic agent
12/22/2005WO2005120173A2 Anti-microbial activity of biologically stabilized silver nano particles
12/22/2005WO2005120152A2 Cationic lipids and methods of use
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/22/2005WO2005090461A3 Thermoplastic films and methods for making
12/22/2005WO2005082023A3 Heterocyclic self-immolative linkers and conjugates
12/22/2005WO2005060945A3 Intranasal compositions comprising zolpidem
12/22/2005WO2005052116A3 Preservative-containing virus formulations
12/22/2005WO2005042029A3 Psma formulations and uses thereof
12/22/2005WO2005025623A3 Ef-24-factor vii conjugates
12/22/2005WO2005023233A3 Antimicrobial compositions and methods
12/22/2005WO2004093823A3 Polyethelene glycol link glp-1 compounds
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283098 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282869 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
12/22/2005US20050282839 Pyrimidyl phosphonate antiviral compounds and methods of use
12/22/2005US20050282783 Obtained by reacting sodium zoledronate with calcium orthophosphates in water, bone remodeling equilibrium; the local treatment of a bone problem on the main at-risk sites identified (neck of the femur )
12/22/2005US20050282776 Injectable pharmaceutical compositions comprising sodium diclofenac and beta-cyclodextrin
12/22/2005US20050282774 Method and pharmaceutical to treat spinal discs
12/22/2005US20050282773 Modified polysaccharides in combination with anti-cancer drugs for enhanced treatment of cancer
12/22/2005US20050282759 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
12/22/2005US20050282756 Oral delivery of peptide pharmaceutical compositions
12/22/2005US20050282752 IL-1ra variants
12/22/2005US20050282747 Methods and compositions for wound healing
12/22/2005US20050282740 Methods and compositions for regulating protein-protein interactions
12/22/2005US20050282734 Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
12/22/2005US20050282731 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
12/22/2005US20050282271 Cell; extracellular, plasma membrane associated cyto-compatible glycoconjugate, a monosaccharide; cancer diagnosis
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282168 Cell surface molecules as markers and therapeutic agents against kidney cancers
12/22/2005US20050281910 Method for increasing pet activity
12/22/2005US20050281884 Unagglomerated core/shell nanocomposite particles
12/22/2005US20050281883 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
12/22/2005US20050281880 Methods for making injectable polymer hydrogels
12/22/2005US20050281879 Injectable gel; moderating releasing
12/22/2005US20050281873 Universal controlled-release composition
12/22/2005US20050281864 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock
12/22/2005US20050281861 Macromolecule-containing sustained release intraocular implants and related methods
12/22/2005US20050281850 Cosmetic/dermatological inverse emulsions containing calcitriol and clobetasol 17-propionate
12/22/2005US20050281845 Hapten-carrier conjugates and uses thereof
12/22/2005US20050281832 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
12/22/2005US20050281820 Administering to a burn an anticytokine or antiinflammatory agent and a pharmaceutically excipient; administering to a mammal having a burn injury:sodium monofluorophosphate and a dihydrofolate reductase inhibitor of aminopterin, methotrexate, pyramethamine, trimethoprim or derivatives
12/22/2005US20050281806 Compositions for topical enzymatic debridement
12/22/2005US20050281804 Administering human recombinant alpha -L-iduronidase, carrier and polysorbate for therapy of mucopolysaccharidosis
12/22/2005US20050281802 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd
12/22/2005US20050281801 Glue composition for lung volume reduction
12/22/2005US20050281800 Targeting sites of damaged lung tissue
12/22/2005US20050281799 Targeting damaged lung tissue using compositions
1 ... 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 ... 1712